YOCHANRA
LIVE

Serial Number

79348522

Owner

TransThera Sciences (Nanjing), Inc.

Attorney

Michael T. Smith

Filing Date

Jun 10, 2022

Add to watchlist:

No watchlists yet
View on USPTO

YOCHANRA Trademark

Serial Number: 79348522 • Registration: 7518200

YOCHANRA is a trademark filed by TransThera Sciences (Nanjing), Inc. on June 10, 2022. The trademark is classified under Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

TransThera Sciences (Nanjing), Inc. (10 trademarks)

Flr. 3, Bld. 9, Accelerator Phase 2,

Entity Type: 03

Trademark Details

Filing Date

June 10, 2022

Registration Date

October 1, 2024

Published for Opposition

July 16, 2024

Goods & Services

Presentation of goods on communication media in the nature of providing television home shopping services and operating an online shopping site for retail purposes featuring pharmaceutical products and medical supplies; market studies in pharmaceutical field; publicity in pharmaceutical field; advertising in pharmaceutical field; marketing in pharmaceutical field; provision of an online marketplace for buyers and sellers of goods and services in pharmaceutical field; import-export agency services in pharmaceutical field; sponsorship search in pharmaceutical field; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies

Medical clinic services; telemedicine services; physical therapy services; medical consulting service; medical assistance; health care; hospital services; gene testing service for medical purpose; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; pharmacy advice in the nature of pharmceutical advice

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 22, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 4, 2025 FICS
FINAL DISPOSITION PROCESSED
Mar 4, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 1, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 1, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 1, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 16, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 16, 2024 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 16, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 16, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 26, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 10, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 5, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 5, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jun 5, 2024 ERFR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 26, 2024 OPNX
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Feb 15, 2024 GNS1
CONTINUATION OF FINAL REFUSAL E-MAILED
Feb 15, 2024 GNCF
ACTION CONTINUING A FINAL - COMPLETED
Feb 15, 2024 CNCF
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 7, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 7, 2024 OPNR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 31, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 30, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 30, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 18, 2023 GNFN
FINAL REFUSAL E-MAILED
Sep 18, 2023 GNFR
FINAL REFUSAL WRITTEN
Sep 18, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 24, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 24, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 24, 2023 TROA
REFUSAL PROCESSED BY IB
May 17, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 25, 2023 RFCS
REFUSAL PROCESSED BY MPU
Apr 25, 2023 RFRR
NEW REPRESENTATIVE AT IB RECEIVED
Apr 9, 2023 NREP
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 4, 2023 RFCR
NON-FINAL ACTION WRITTEN
Mar 3, 2023 CNRT
ASSIGNED TO EXAMINER
Feb 25, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 13, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 8, 2022 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 7, 2022 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 1, 2022 REPR